Literature DB >> 30461303

Disruption of cardiac Med1 inhibits RNA polymerase II promoter occupancy and promotes chromatin remodeling.

Duane D Hall1, Kathryn M Spitler1, Chad E Grueter1.   

Abstract

The Mediator coactivator complex directs gene-specific expression by binding distal enhancer-bound transcription factors through its Med1 subunit while bridging to RNA polymerase II (Pol II) at gene promoters. In addition, Mediator scaffolds epigenetic modifying enzymes that determine local DNA accessibility. Previously, we found that deletion of Med1 in cardiomyocytes deregulates more than 5,000 genes and promotes acute heart failure. Therefore, we hypothesized that Med1 deficiency disrupts enhancer-promoter coupling. Using chromatin immunoprecipitation-coupled deep sequencing (ChIP-seq; n = 3/ChIP assay), we found that the Pol II pausing index is increased in Med1 knockout versus floxed control mouse hearts primarily due to a decrease in Pol II occupancy at the majority of transcriptional start sites without a corresponding increase in elongating species. Parallel ChIP-seq assays reveal that Med1-dependent gene expression correlates strongly with histone H3 K27 acetylation, which is indicative of open and active chromatin at transcriptional start sites, whereas H3 K27 trimethylated levels, representing condensed and repressed DNA, are broadly increased and inversely correlate with absolute expression levels. Furthermore, Med1 deletion leads to dynamic changes in acetyl-K27 associated superenhancer regions and their enriched transcription factor-binding motifs that are consistent with altered gene expression. Our findings suggest that Med1 is important in establishing enhancer-promoter coupling in the heart and supports the proposed role of Mediator in establishing preinitiation complex formation. We also found that Med1 determines chromatin accessibility within genes and enhancer regions and propose that the composition of transcription factors associated with superenhancer changes to direct gene-specific expression. NEW & NOTEWORTHY Based on our previous findings that transcriptional homeostasis and cardiac function are disturbed by cardiomyocyte deletion of the Mediator coactivator Med1 subunit, we investigated potential underlying changes in RNA polymerase II localization and global chromatin accessibility. Using chromatin immunoprecipitation sequencing, we found that disrupted transcription arises from a deficit in RNA polymerase II recruitment to gene promoters. Furthermore, active versus repressive chromatin marks are redistributed within gene loci and at enhancer regions correlated with gene expression changes.

Entities:  

Keywords:  RNA polymerase II; chromatin immunoprecipitation-coupled deep sequencing; enhancer; heart; histone H3 lysine 27; mediator

Mesh:

Substances:

Year:  2018        PMID: 30461303      PMCID: PMC6397381          DOI: 10.1152/ajpheart.00580.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  52 in total

1.  Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.

Authors:  Stephen C J Parker; Michael L Stitzel; D Leland Taylor; Jose Miguel Orozco; Michael R Erdos; Jennifer A Akiyama; Kelly Lammerts van Bueren; Peter S Chines; Narisu Narisu; Brian L Black; Axel Visel; Len A Pennacchio; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

2.  Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming.

Authors:  Kathryn M Spitler; Jessica M Ponce; Gavin Y Oudit; Duane D Hall; Chad E Grueter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 4.733

3.  Mediator Undergoes a Compositional Change during Transcriptional Activation.

Authors:  Natalia Petrenko; Yi Jin; Koon Ho Wong; Kevin Struhl
Journal:  Mol Cell       Date:  2016-10-20       Impact factor: 17.970

4.  A cardiac microRNA governs systemic energy homeostasis by regulation of MED13.

Authors:  Chad E Grueter; Eva van Rooij; Brett A Johnson; Susan M DeLeon; Lillian B Sutherland; Xiaoxia Qi; Laurent Gautron; Joel K Elmquist; Rhonda Bassel-Duby; Eric N Olson
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

5.  Reversible Regulation of Promoter and Enhancer Histone Landscape by DNA Methylation in Mouse Embryonic Stem Cells.

Authors:  Andrew D King; Kevin Huang; Liudmilla Rubbi; Shuo Liu; Cun-Yu Wang; Yinsheng Wang; Matteo Pellegrini; Guoping Fan
Journal:  Cell Rep       Date:  2016-09-27       Impact factor: 9.423

6.  BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.

Authors:  Jessica I Spiltoir; Matthew S Stratton; Maria A Cavasin; Kim Demos-Davies; Brian G Reid; Jun Qi; James E Bradner; Timothy A McKinsey
Journal:  J Mol Cell Cardiol       Date:  2013-08-09       Impact factor: 5.000

7.  Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs.

Authors:  Scot J Matkovich; John R Edwards; Tiffani C Grossenheider; Cristina de Guzman Strong; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

8.  Model-based analysis of ChIP-Seq (MACS).

Authors:  Yong Zhang; Tao Liu; Clifford A Meyer; Jérôme Eeckhoute; David S Johnson; Bradley E Bernstein; Chad Nusbaum; Richard M Myers; Myles Brown; Wei Li; X Shirley Liu
Journal:  Genome Biol       Date:  2008-09-17       Impact factor: 13.583

9.  Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice.

Authors:  Yuzhi Jia; Hsiang-Chun Chang; Matthew J Schipma; Jing Liu; Varsha Shete; Ning Liu; Tatsuya Sato; Edward B Thorp; Philip M Barger; Yi-Jun Zhu; Navin Viswakarma; Yashpal S Kanwar; Hossein Ardehali; Bayar Thimmapaya; Janardan K Reddy
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

10.  Lysine-specific demethylase 1 promotes brown adipose tissue thermogenesis via repressing glucocorticoid activation.

Authors:  Xing Zeng; Mark P Jedrychowski; Yi Chen; Sara Serag; Gareth G Lavery; Steve P Gygi; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2016-08-26       Impact factor: 11.361

View more
  5 in total

Review 1.  Targeting transcriptional machinery to inhibit enhancer-driven gene expression in heart failure.

Authors:  Rachel A Minerath; Duane D Hall; Chad E Grueter
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

2.  Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy.

Authors:  Chia-Feng Liu; Armen Abnousi; Peter Bazeley; Ying Ni; Michael Morley; Christine S Moravec; Ming Hu; W H Wilson Tang
Journal:  J Mol Cell Cardiol       Date:  2020-06-10       Impact factor: 5.000

3.  Histone Acetylation Domains Are Differentially Induced during Development of Heart Failure in Dahl Salt-Sensitive Rats.

Authors:  Masafumi Funamoto; Yoichi Sunagawa; Yasufumi Katanasaka; Kana Shimizu; Yusuke Miyazaki; Nurmila Sari; Satoshi Shimizu; Kiyoshi Mori; Hiromichi Wada; Koji Hasegawa; Tatsuya Morimoto
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 5.923

4.  Predictive Biomarkers for Postmyocardial Infarction Heart Failure Using Machine Learning: A Secondary Analysis of a Cohort Study.

Authors:  Feng Li; Jin-Yu Sun; Li-Da Wu; Qiang Qu; Zhen-Ye Zhang; Xu-Fei Chen; Jun-Yan Kan; Chao Wang; Ru-Xing Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-13       Impact factor: 2.629

5.  Stress-Induced Cyclin C Translocation Regulates Cardiac Mitochondrial Dynamics.

Authors:  Jessica M Ponce; Grace Coen; Kathryn M Spitler; Nikola Dragisic; Ines Martins; Antentor Hinton; Margaret Mungai; Satya Murthy Tadinada; Hao Zhang; Gavin Y Oudit; Long-Sheng Song; Na Li; Peter Sicinski; Stefan Strack; E Dale Abel; Colleen Mitchell; Duane D Hall; Chad E Grueter
Journal:  J Am Heart Assoc       Date:  2020-04-04       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.